CINXE.COM
Publications — CIMT
<!doctype html> <html xmlns:og="http://opengraphprotocol.org/schema/" xmlns:fb="http://www.facebook.com/2008/fbml" lang="en-US" > <head> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"> <meta name="viewport" content="initial-scale=1"> <!-- This is Squarespace. --><!-- mustard-hen-pywg --> <base href=""> <meta charset="utf-8" /> <title>Publications — CIMT</title> <meta http-equiv="Accept-CH" content="Sec-CH-UA-Platform-Version, Sec-CH-UA-Model" /><link rel="icon" type="image/x-icon" href="https://assets.squarespace.com/universal/default-favicon.ico"/> <link rel="canonical" href="https://www.cimt.eu/publications-1"/> <meta property="og:site_name" content="CIMT"/> <meta property="og:title" content="Publications — CIMT"/> <meta property="og:url" content="https://www.cimt.eu/publications-1"/> <meta property="og:type" content="website"/> <meta itemprop="name" content="Publications — CIMT"/> <meta itemprop="url" content="https://www.cimt.eu/publications-1"/> <meta name="twitter:title" content="Publications — CIMT"/> <meta name="twitter:url" content="https://www.cimt.eu/publications-1"/> <meta name="twitter:card" content="summary"/> <meta name="description" content="" /> <link rel="preconnect" href="https://images.squarespace-cdn.com"> <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css2?family=Fjalla+One:wght@400&family=Libre+Franklin:ital,wght@0,400;0,500;0,700;1,400;1,700&family=Titillium+Web:ital,wght@0,300;0,400;0,600;0,700;1,300;1,600;1,700"> <script type="text/javascript" crossorigin="anonymous" nomodule="nomodule" src="//assets.squarespace.com/@sqs/polyfiller/1.6/legacy.js"></script> <script type="text/javascript" crossorigin="anonymous" src="//assets.squarespace.com/@sqs/polyfiller/1.6/modern.js"></script> <script type="text/javascript">SQUARESPACE_ROLLUPS = {};</script> <script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/extract-css-runtime-ebfa92978b19cf630135-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-extract_css_runtime');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/extract-css-runtime-ebfa92978b19cf630135-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/extract-css-moment-js-vendor-6c569122bfa66a51a056-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-extract_css_moment_js_vendor');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/extract-css-moment-js-vendor-6c569122bfa66a51a056-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/cldr-resource-pack-32136deb9638cc6130b2-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-cldr_resource_pack');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/cldr-resource-pack-32136deb9638cc6130b2-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/common-vendors-stable-61293f01d648eef165fc-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-common_vendors_stable');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/common-vendors-stable-61293f01d648eef165fc-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/common-vendors-be0091dc488b10891ed6-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-common_vendors');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/common-vendors-be0091dc488b10891ed6-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/common-4cd0c6f08f784ee57513-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-common');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/common-4cd0c6f08f784ee57513-min.en-US.js" ></script><script>(function(rollups, name) { if (!rollups[name]) { rollups[name] = {}; } rollups[name].js = ["//assets.squarespace.com/universal/scripts-compressed/performance-d9f618c1beaea97b6499-min.en-US.js"]; })(SQUARESPACE_ROLLUPS, 'squarespace-performance');</script> <script crossorigin="anonymous" src="//assets.squarespace.com/universal/scripts-compressed/performance-d9f618c1beaea97b6499-min.en-US.js" defer ></script><script data-name="static-context">Static = window.Static || {}; Static.SQUARESPACE_CONTEXT = {"betaFeatureFlags":["pages_panel_v3_search_bar","scripts_defer","commerce_clearpay","is_feature_gate_refresh_enabled","campaigns_discount_section_in_blasts","enable_css_variable_tweaks","blueprint_content_replacement","accounting_orders_sync","hide_header_footer_beta","commerce_site_visitor_metrics","contacts_and_campaigns_redesign","order_status_page_checkout_landing_enabled","nested_categories_migration_enabled","gdpr_cookie_banner","hideable_header_footer_for_videos","campaigns_import_discounts","campaigns_thumbnail_layout","hideable_header_footer_for_courses","visitor_react_forms","i18n_beta_website_locales","hideable_header_footer","hideable_header_footer_for_memberareas","unify_edit_mode_p2","campaigns_discount_section_in_automations","campaigns_new_image_layout_picker","campaigns_black_friday_banners","fluid_engine","marketing_landing_page","campaigns_global_uc_ab","fluid_engine_clean_up_grid_contextual_change","toggle_preview_new_shortcut"],"videoAssetsFeatureFlags":["mux-data-video-collection","mux-data-course-collection","mux-data-video-block-autoplay"],"facebookAppId":"314192535267336","facebookApiVersion":"v6.0","rollups":{"squarespace-announcement-bar":{"js":"//assets.squarespace.com/universal/scripts-compressed/announcement-bar-abc247145d9c909b7ca1-min.en-US.js"},"squarespace-audio-player":{"css":"//assets.squarespace.com/universal/styles-compressed/audio-player-ef238f99d44a3bdc6fbe-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/audio-player-7b2d6f5ce8ae62cf892f-min.en-US.js"},"squarespace-blog-collection-list":{"css":"//assets.squarespace.com/universal/styles-compressed/blog-collection-list-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/blog-collection-list-44fda292525bdeb0ee8a-min.en-US.js"},"squarespace-calendar-block-renderer":{"css":"//assets.squarespace.com/universal/styles-compressed/calendar-block-renderer-b15e2d46a617c8add4b4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/calendar-block-renderer-ba9e797b1c6edb9a3bac-min.en-US.js"},"squarespace-chartjs-helpers":{"css":"//assets.squarespace.com/universal/styles-compressed/chartjs-helpers-9e75b5d75bb5cb4c1f67-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/chartjs-helpers-6f4b03f58cff68354645-min.en-US.js"},"squarespace-comments":{"css":"//assets.squarespace.com/universal/styles-compressed/comments-a0d9356d7c1596ab2c53-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/comments-80a567d7afca7ea1dbfe-min.en-US.js"},"squarespace-custom-css-popup":{"css":"//assets.squarespace.com/universal/styles-compressed/custom-css-popup-d6e0f953c836d9289b10-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/custom-css-popup-67e79c564ae532a1d776-min.en-US.js"},"squarespace-dialog":{"css":"//assets.squarespace.com/universal/styles-compressed/dialog-2dcac307baebe70727dc-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/dialog-dbb8daeadaf90e62b274-min.en-US.js"},"squarespace-events-collection":{"css":"//assets.squarespace.com/universal/styles-compressed/events-collection-b15e2d46a617c8add4b4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/events-collection-297bf44c7cd0c7f15d78-min.en-US.js"},"squarespace-form-rendering-utils":{"js":"//assets.squarespace.com/universal/scripts-compressed/form-rendering-utils-a92219a77cf6d4679390-min.en-US.js"},"squarespace-forms":{"css":"//assets.squarespace.com/universal/styles-compressed/forms-b952cddb94c5d471b8d3-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/forms-49fd9d5237aa589917dd-min.en-US.js"},"squarespace-gallery-collection-list":{"css":"//assets.squarespace.com/universal/styles-compressed/gallery-collection-list-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/gallery-collection-list-dabc951e1bbbe8467525-min.en-US.js"},"squarespace-image-zoom":{"css":"//assets.squarespace.com/universal/styles-compressed/image-zoom-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/image-zoom-485cb3cf26fda8199e47-min.en-US.js"},"squarespace-pinterest":{"css":"//assets.squarespace.com/universal/styles-compressed/pinterest-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/pinterest-7ad9f70c56d9c6b0ae65-min.en-US.js"},"squarespace-popup-overlay":{"css":"//assets.squarespace.com/universal/styles-compressed/popup-overlay-e89b4cc96c222ed66c64-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/popup-overlay-ece7db5c4bfceb54a50a-min.en-US.js"},"squarespace-product-quick-view":{"css":"//assets.squarespace.com/universal/styles-compressed/product-quick-view-2f87c3dcb76ca485179d-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/product-quick-view-3c6b64e906196e37ee93-min.en-US.js"},"squarespace-products-collection-item-v2":{"css":"//assets.squarespace.com/universal/styles-compressed/products-collection-item-v2-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/products-collection-item-v2-1ed64b36a5caefb0bf3d-min.en-US.js"},"squarespace-products-collection-list-v2":{"css":"//assets.squarespace.com/universal/styles-compressed/products-collection-list-v2-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/products-collection-list-v2-91090125416a47e4fecb-min.en-US.js"},"squarespace-search-page":{"css":"//assets.squarespace.com/universal/styles-compressed/search-page-917382e71b023cec7555-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/search-page-9f4098985bf13af25db5-min.en-US.js"},"squarespace-search-preview":{"js":"//assets.squarespace.com/universal/scripts-compressed/search-preview-4e7434a694d83d8766a0-min.en-US.js"},"squarespace-simple-liking":{"css":"//assets.squarespace.com/universal/styles-compressed/simple-liking-4279cc7bb78333b8db43-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/simple-liking-f5b368f59d68ab9f9480-min.en-US.js"},"squarespace-social-buttons":{"css":"//assets.squarespace.com/universal/styles-compressed/social-buttons-3a7d186e7e5e3b30911b-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/social-buttons-b71ef5af6c65212fb342-min.en-US.js"},"squarespace-tourdates":{"css":"//assets.squarespace.com/universal/styles-compressed/tourdates-8ec841cacfb75d4282f4-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/tourdates-22e5cff21f07efe64af0-min.en-US.js"},"squarespace-website-overlays-manager":{"css":"//assets.squarespace.com/universal/styles-compressed/website-overlays-manager-efd3c12d460f58781eb3-min.en-US.css","js":"//assets.squarespace.com/universal/scripts-compressed/website-overlays-manager-db7ec709521a62f0b755-min.en-US.js"}},"pageType":2,"website":{"id":"5b291a7ef2e6b15350bc6d77","identifier":"mustard-hen-pywg","websiteType":1,"contentModifiedOn":1732117818774,"cloneable":false,"hasBeenCloneable":false,"siteStatus":{},"language":"en-US","timeZone":"America/New_York","machineTimeZoneOffset":-18000000,"timeZoneOffset":-18000000,"timeZoneAbbr":"EST","siteTitle":"CIMT","fullSiteTitle":"Publications \u2014 CIMT","siteDescription":"<p>The Association for Cancer Immunotherapy CIMT is a member-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization.</p>","logoImageId":"5b3e5209352f53933a9906cf","shareButtonOptions":{"1":true,"6":true,"4":true,"3":true,"7":true,"8":true,"2":true},"logoImageUrl":"//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png","authenticUrl":"https://www.cimt.eu","internalUrl":"https://mustard-hen-pywg.squarespace.com","baseUrl":"https://www.cimt.eu","primaryDomain":"www.cimt.eu","sslSetting":3,"isHstsEnabled":false,"typekitId":"","statsMigrated":false,"imageMetadataProcessingEnabled":false,"screenshotId":"884ee3ce2cabc8dacec870d6281bdbff8fa7d3967569abaf3046ce495a02f9e4","showOwnerLogin":false},"websiteSettings":{"id":"5b291a7ef2e6b15350bc6d7a","websiteId":"5b291a7ef2e6b15350bc6d77","type":"Non-Profit","subjects":[],"country":"US","state":"VA","simpleLikingEnabled":true,"mobileInfoBarSettings":{"isContactEmailEnabled":false,"isContactPhoneNumberEnabled":false,"isLocationEnabled":false,"isBusinessHoursEnabled":false},"commentLikesAllowed":true,"commentAnonAllowed":true,"commentThreaded":true,"commentApprovalRequired":false,"commentAvatarsOn":true,"commentSortType":2,"commentFlagThreshold":0,"commentFlagsAllowed":true,"commentEnableByDefault":true,"commentDisableAfterDaysDefault":0,"disqusShortname":"","commentsEnabled":false,"storeSettings":{"returnPolicy":null,"termsOfService":null,"privacyPolicy":null,"expressCheckout":false,"continueShoppingLinkUrl":"/","useLightCart":false,"showNoteField":false,"shippingCountryDefaultValue":"US","billToShippingDefaultValue":false,"showShippingPhoneNumber":true,"isShippingPhoneRequired":false,"showBillingPhoneNumber":true,"isBillingPhoneRequired":false,"currenciesSupported":["CHF","HKD","MXN","EUR","DKK","USD","CAD","MYR","NOK","THB","AUD","SGD","ILS","PLN","GBP","CZK","SEK","NZD","PHP","RUB"],"defaultCurrency":"USD","selectedCurrency":"USD","measurementStandard":1,"showCustomCheckoutForm":false,"checkoutPageMarketingOptInEnabled":false,"enableMailingListOptInByDefault":false,"sameAsRetailLocation":false,"merchandisingSettings":{"scarcityEnabledOnProductItems":false,"scarcityEnabledOnProductBlocks":false,"scarcityMessageType":"DEFAULT_SCARCITY_MESSAGE","scarcityThreshold":10,"multipleQuantityAllowedForServices":true,"restockNotificationsEnabled":false,"restockNotificationsSuccessText":"","restockNotificationsMailingListSignUpEnabled":false,"relatedProductsEnabled":false,"relatedProductsOrdering":"random","soldOutVariantsDropdownDisabled":false,"productComposerOptedIn":false,"productComposerABTestOptedOut":false,"productReviewsEnabled":false,"displayImportedProductReviewsEnabled":false,"hasOptedToCollectNativeReviews":false},"minimumOrderSubtotalEnabled":false,"isLive":false,"multipleQuantityAllowedForServices":true},"useEscapeKeyToLogin":true,"ssBadgeType":1,"ssBadgePosition":4,"ssBadgeVisibility":1,"ssBadgeDevices":1,"pinterestOverlayOptions":{"mode":"disabled"},"ampEnabled":false,"userAccountsSettings":{"loginAllowed":false,"signupAllowed":false}},"cookieSettings":{"isCookieBannerEnabled":false,"isRestrictiveCookiePolicyEnabled":false,"cookieBannerText":"","cookieBannerTheme":"","cookieBannerVariant":"","cookieBannerPosition":"","cookieBannerCtaVariant":"","cookieBannerCtaText":"","cookieBannerAcceptType":"OPT_IN","cookieBannerOptOutCtaText":"","cookieBannerHasOptOut":false,"cookieBannerHasManageCookies":true,"cookieBannerManageCookiesLabel":"","cookieBannerSavedPreferencesText":"","cookieBannerSavedPreferencesLayout":"PILL"},"websiteCloneable":false,"collection":{"title":"Publications","id":"5b6c309e8a922d23fb11ab49","fullUrl":"/publications-1","type":10,"permissionType":1},"subscribed":false,"appDomain":"squarespace.com","templateTweakable":true,"tweakJSON":{"aspect-ratio":"Auto","gallery-arrow-style":"No Background","gallery-aspect-ratio":"3:2 Standard","gallery-auto-crop":"true","gallery-autoplay":"false","gallery-design":"Slideshow","gallery-info-overlay":"Show on Hover","gallery-loop":"false","gallery-navigation":"Bullets","gallery-show-arrows":"true","gallery-transitions":"Fade","galleryArrowBackground":"rgba(34,34,34,1)","galleryArrowColor":"rgba(255,255,255,1)","galleryAutoplaySpeed":"3","galleryCircleColor":"rgba(255,255,255,1)","galleryInfoBackground":"rgba(0, 0, 0, .7)","galleryThumbnailSize":"100px","gridSize":"350px","gridSpacing":"20px","tweak-blog-list-columns":"3","tweak-blog-list-item-image-aspect-ratio-grid":"1:1 Square","tweak-blog-list-item-image-aspect-ratio-stacked":"1:1 Square","tweak-blog-list-item-image-show":"false","tweak-blog-list-spacing":"50px","tweak-blog-list-style":"Grid","tweak-footer-layout":"Columns","tweak-header-bottom-overlay-on-index-gallery":"true","tweak-index-gallery-apply-bottom-spacing":"true","tweak-index-gallery-autoplay-duration":"2","tweak-index-gallery-autoplay-enable":"true","tweak-index-gallery-fixed-height":"true","tweak-index-gallery-height":"100vh","tweak-index-gallery-indicators":"Lines","tweak-index-gallery-layout":"Grid","tweak-index-gallery-transition":"Fade","tweak-index-gallery-transition-duration":"500","tweak-index-nav-position":"Right","tweak-index-page-apply-bottom-spacing":"false","tweak-index-page-fullscreen":"None","tweak-index-page-min-height":"50vh","tweak-mobile-breakpoint":"640px","tweak-overlay-parallax-enabled":"true","tweak-overlay-parallax-new-math":"true","tweak-product-item-image-zoom-factor":"2.5","tweak-product-list-item-hover-behavior":"Show Alternate Image","tweak-product-list-items-per-row":"4","tweak-related-products-items-per-row":"3","tweak-related-products-title-spacing":"50px","tweak-site-ajax-loading-enable":"false","tweak-site-border-show":"false","tweak-site-border-width":"1px"},"templateId":"55f0aac0e4b0f0a5b7e0b22e","templateVersion":"7","pageFeatures":[1,2,4],"gmRenderKey":"QUl6YVN5Q0JUUk9xNkx1dkZfSUUxcjQ2LVQ0QWVUU1YtMGQ3bXk4","templateScriptsRootUrl":"https://static1.squarespace.com/static/ta/55f0a9b0e4b0f3eb70352f6d/354/scripts/","impersonatedSession":false,"tzData":{"zones":[[-300,"US","E%sT",null]],"rules":{"US":[[1967,2006,null,"Oct","lastSun","2:00","0","S"],[1987,2006,null,"Apr","Sun>=1","2:00","1:00","D"],[2007,"max",null,"Mar","Sun>=8","2:00","1:00","D"],[2007,"max",null,"Nov","Sun>=1","2:00","0","S"]]}},"showAnnouncementBar":false,"recaptchaEnterpriseContext":{"recaptchaEnterpriseSiteKey":"6LdDFQwjAAAAAPigEvvPgEVbb7QBm-TkVJdDTlAv"},"i18nContext":{"timeZoneData":{"id":"America/New_York","name":"Eastern Time"}},"env":"PRODUCTION"};</script><script>Squarespace.load(window);</script> <script type="application/ld+json">{"url":"https://www.cimt.eu","name":"CIMT","description":"<p>The Association for Cancer Immunotherapy CIMT is a member-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization.</p>","image":"//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png","@context":"http://schema.org","@type":"WebSite"}</script><link rel="stylesheet" type="text/css" href="https://static1.squarespace.com/static/sitecss/5b291a7ef2e6b15350bc6d77/354/55f0aac0e4b0f0a5b7e0b22e/5b291a7ff2e6b15350bc6d8e/354/site.css"/><script src="https://ajax.googleapis.com/ajax/libs/jquery/2.2.0/jquery.min.js"></script> <script> $(function() { init(); }); //Start the code when the page loads function init(){ var $list = $('.sqs-block-markdown').nextUntil('.sqs-block-markdown, .sqs-block-sqs-block-horizontalrule').slideUp(0); //Your code (wrapped in a function) $list.next().hide(); $('.sqs-block-markdown').unbind().click(function(){ $('.sqs-block-markdown').not(this).nextUntil('.sqs-block-markdown, .sqs-block-horizontalrule').slideUp(), $('.sqs-block-markdown').not(this).removeClass('activedrop'), $(this).nextUntil('.sqs-block-markdown, .sqs-block-horizontalrule').slideToggle(); }); $('.sqs-block-markdown').css('cursor','pointer'); } document.addEventListener('pageChange', function(){ //When the change page event fires due to ajax init(); //Call the code again }); /*This stuff listens for an ajax page change*/ window.onload = watch; function watch(){MutationObserver=window.MutationObserver||window.WebKitMutationObserver;var a=new MutationObserver(function(a){for(var b=0;b<a.length;b++){var c=a[b];if("attributes"===c.type){var d=new Event("pageChange");document.dispatchEvent(d)}}});a.observe(document.body,{attributes:!0,attributeFilter:["id"]})} </script> <script> $(document).ready(function(){ $(".sqs-block-markdown").click(function() {$(this).toggleClass('activedrop');}); }); </script> <style> .sqs-block-markdown { cursor:pointer; font-weight: bold; padding-bottom: 0; margin-bottom: 30px; transition: margin-bottom: 0.3s; } .sqs-block-markdown.activedrop { margin-bottom: 0; } .sqs-block-markdown > .sqs-block-content { border-bottom: solid 1px #ddd; padding-bottom: 17px; } .sqs-block-markdown .sqs-block-content:before { content: "+"; float: right; font-size: 150%; line-height: 120%; color: #aaa; font-weight: 100; } .activedrop .sqs-block-content:before { content: "-" !important; float: right; font-size: 150%; line-height: 100%; color: #aaa; font-weight: 100; } </style><style> .Header { background: #da026c; } </style> <script src="//ajax.googleapis.com/ajax/libs/jquery/2.2.2/jquery.min.js"> </script> <script> $(function() {$('.Header-branding-logo') .attr('src', 'https://static1.squarespace.com/static/5b291a7ef2e6b15350bc6d77/t/5b6ab7c3758d4610026417ec/1533720515807/CIP_Logo_weiss_Rand.png')}) </script> <style> [data-nc-element="primary-nav"]{ display:none; } </style><script>Static.COOKIE_BANNER_CAPABLE = true;</script> <!-- End of Squarespace Headers --> </head> <body id="collection-5b6c309e8a922d23fb11ab49" class="tweak-social-icons-style-solid tweak-social-icons-shape-square tweak-site-width-option-full-background tweak-icon-weight-medium ancillary-header-top-left-layout-horizontal ancillary-header-top-center-layout-horizontal ancillary-header-top-right-layout-horizontal ancillary-header-bottom-left-layout-horizontal ancillary-header-bottom-center-layout-horizontal ancillary-header-bottom-right-layout-horizontal ancillary-header-branding-position-bottom-left ancillary-header-tagline-position-hide ancillary-header-primary-nav-position-bottom-center ancillary-header-secondary-nav-position-bottom-center ancillary-header-social-position-hide ancillary-header-search-position-hide ancillary-header-cart-position-hide ancillary-header-account-position-hide tweak-header-primary-nav-hover-style-active tweak-header-primary-nav-button-style-solid tweak-header-primary-nav-button-shape-square tweak-header-secondary-nav-hover-style-active tweak-header-secondary-nav-button-style-solid tweak-header-secondary-nav-button-shape-square tweak-header-search-style-underlined tweak-header-search-placeholder-show tweak-header-cart-style-text tweak-header-account-style-text tweak-overlay-parallax-enabled tweak-overlay-parallax-new-math tweak-index-nav-style-none tweak-index-nav-position-right tweak-index-nav-text-show tweak-index-page-fullscreen-none tweak-index-page-scroll-indicator-none tweak-index-page-scroll-indicator-icon-arrow tweak-index-page-scroll-indicator-icon-weight-hairline tweak-header-bottom-overlay-on-index-gallery tweak-index-gallery-layout-grid tweak-index-gallery-spacing-sides-show tweak-index-gallery-spacing-top-bottom-show tweak-index-gallery-fixed-height tweak-index-gallery-apply-bottom-spacing tweak-index-gallery-hover-style-plain tweak-index-gallery-controls-small-arrows tweak-index-gallery-controls-icon-weight-hairline tweak-index-gallery-indicators-lines tweak-index-gallery-autoplay-enable tweak-index-gallery-transition-fade tweak-index-gallery-content-position-middle-center tweak-index-gallery-content-text-alignment-center tweak-footer-show tweak-footer-layout-columns tweak-footer-layout-columns-auto tweak-footer-stacked-alignment-left tweak-footer-business-info-show ancillary-mobile-bar-branding-position-top-left ancillary-mobile-bar-menu-icon-position-top-right tweak-mobile-bar-menu-icon-hamburger ancillary-mobile-bar-search-icon-position-hide ancillary-mobile-bar-cart-position-hide tweak-mobile-bar-cart-style-text ancillary-mobile-bar-account-position-hide tweak-mobile-bar-account-style-text tweak-mobile-overlay-slide-origin-left tweak-mobile-overlay-close-show tweak-mobile-overlay-menu-primary-button-style-solid tweak-mobile-overlay-menu-primary-button-shape-square tweak-mobile-overlay-menu-secondary-button-style-solid tweak-mobile-overlay-menu-secondary-button-shape-square tweak-quote-block-alignment-left tweak-blog-meta-primary-date tweak-blog-meta-secondary-none tweak-blog-list-style-grid tweak-blog-list-separator-show tweak-blog-list-alignment-left tweak-blog-list-item-image-aspect-ratio-grid-11-square tweak-blog-list-item-image-aspect-ratio-stacked-11-square tweak-blog-list-item-title-show tweak-blog-list-item-excerpt-show tweak-blog-list-item-body-show tweak-blog-list-item-readmore-below-excerpt tweak-blog-list-item-meta-position-above-title tweak-blog-list-pagination-link-label-show tweak-blog-list-pagination-link-icon-show tweak-blog-list-pagination-link-icon-weight-light tweak-blog-item-alignment-center tweak-blog-item-meta-position-below-title tweak-blog-item-share-position-below-content tweak-blog-item-pagination-link-icon-show tweak-blog-item-pagination-link-title-show tweak-blog-item-pagination-link-meta-hide tweak-blog-item-pagination-link-icon-weight-light event-thumbnails event-thumbnail-size-32-standard event-date-label event-list-show-cats event-list-date event-list-time event-list-address event-excerpts event-item-back-link gallery-design-slideshow aspect-ratio-auto lightbox-style-dark gallery-navigation-bullets gallery-info-overlay-show-on-hover gallery-aspect-ratio-32-standard gallery-arrow-style-no-background gallery-transitions-fade gallery-show-arrows gallery-auto-crop tweak-product-list-image-aspect-ratio-11-square tweak-product-list-item-hover-behavior-show-alternate-image tweak-product-list-meta-position-under tweak-product-list-mobile-meta-position-under tweak-product-list-meta-alignment-under-left tweak-product-list-meta-alignment-overlay-center-center tweak-product-list-show-title tweak-product-list-show-price tweak-product-list-filter-display-top tweak-product-list-filter-alignment-center tweak-product-item-nav-show-breadcrumb-and-pagination tweak-product-item-nav-pagination-style-previousnext tweak-product-item-nav-breadcrumb-alignment-left tweak-product-item-nav-pagination-alignment-split tweak-product-item-gallery-position-left tweak-product-item-gallery-design-slideshow tweak-product-item-gallery-aspect-ratio-11-square tweak-product-item-gallery-thumbnail-alignment-left tweak-product-item-details-alignment-left tweak-product-item-details-show-title tweak-product-item-details-show-price tweak-product-item-details-show-excerpt tweak-product-item-details-excerpt-position-below-price tweak-product-item-details-show-share-buttons tweak-product-item-details-show-variants tweak-product-item-details-show-quantity tweak-product-item-details-options-style-square tweak-product-item-details-show-add-to-cart-button tweak-product-item-details-add-to-cart-button-style-solid tweak-product-item-details-add-to-cart-button-shape-square tweak-product-item-details-add-to-cart-button-padding-small tweak-product-item-image-zoom-enabled tweak-product-item-image-zoom-behavior-click tweak-product-item-lightbox-enabled tweak-related-products-image-aspect-ratio-11-square tweak-related-products-meta-alignment-under-center tweak-product-badge-style-rectangle tweak-product-badge-position-top-right tweak-product-badge-inset-dock-horizontally newsletter-style-custom hide-opentable-icons opentable-style-dark small-button-style-outline small-button-shape-square medium-button-style-solid medium-button-shape-square large-button-style-solid large-button-shape-square image-block-poster-text-alignment-center image-block-card-dynamic-font-sizing image-block-card-content-position-center image-block-card-text-alignment-left image-block-overlap-dynamic-font-sizing image-block-overlap-content-position-center image-block-overlap-text-alignment-left image-block-collage-dynamic-font-sizing image-block-collage-content-position-top image-block-collage-text-alignment-left image-block-stack-dynamic-font-sizing image-block-stack-text-alignment-left button-style-solid button-corner-style-square tweak-product-quick-view-button-style-floating tweak-product-quick-view-button-position-bottom tweak-product-quick-view-lightbox-excerpt-display-truncate tweak-product-quick-view-lightbox-show-arrows tweak-product-quick-view-lightbox-show-close-button tweak-product-quick-view-lightbox-controls-weight-light tweak-share-buttons-style-icon-only tweak-share-buttons-icons-show tweak-share-buttons-labels-show tweak-share-buttons-counts-show native-currency-code-usd collection-type-page collection-layout-default collection-5b6c309e8a922d23fb11ab49 mobile-style-available sqs-has-custom-cart has-logo-image enable-load-effects has-primary-nav has-secondary-nav" data-controller="HashManager, SiteLoader, MobileClassname"> <div class="Loader"></div> <div class="Mobile" data-nc-base="mobile-bar" data-controller="AncillaryLayout"> <div class="Mobile-bar Mobile-bar--top" data-nc-group="top" data-controller="MobileOffset"> <div data-nc-container="top-left"> <a href="/" class="Mobile-bar-branding" data-nc-element="branding" data-content-field="site-title"> <img src="//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png" alt="CIMT" sizes="240px" class="Mobile-bar-branding-logo" style="display:block" srcset="//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=100w 100w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=300w 300w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=500w 500w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=750w 750w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=1000w 1000w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=1500w 1500w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=2500w 2500w" loading="lazy" decoding="async" data-loader="sqs"> </a> </div> <div data-nc-container="top-center"></div> <div data-nc-container="top-right"></div> </div> <div class="Mobile-bar Mobile-bar--bottom" data-nc-group="bottom" data-controller="MobileOffset"> <div data-nc-container="bottom-left"> <button class="Mobile-bar-menu" data-nc-element="menu-icon" data-controller-overlay="menu" data-controller="MobileOverlayToggle" aria-label="Open navigation menu" > <svg class="Icon Icon--hamburger" viewBox="0 0 24 18"> <use xlink:href="/assets/ui-icons.svg#hamburger-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#hamburger-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--hotdog" viewBox="0 0 24 14"> <use xlink:href="/assets/ui-icons.svg#hotdog-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#hotdog-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--plus" viewBox="0 0 20 20"> <use xlink:href="/assets/ui-icons.svg#plus-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#plus-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--dots-horizontal" viewBox="0 0 25 7"> <use xlink:href="/assets/ui-icons.svg#dots-horizontal-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#dots-horizontal-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--dots-vertical" viewBox="0 0 7 25"> <use xlink:href="/assets/ui-icons.svg#dots-vertical-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#dots-vertical-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--squares-horizontal" viewBox="0 0 25 7"> <use xlink:href="/assets/ui-icons.svg#squares-horizontal-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#squares-horizontal-icon--odd" class="use--odd"></use> </svg> <svg class="Icon Icon--squares-vertical" viewBox="0 0 7 25"> <use xlink:href="/assets/ui-icons.svg#squares-vertical-icon--even" class="use--even"></use> <use xlink:href="/assets/ui-icons.svg#squares-vertical-icon--odd" class="use--odd"></use> </svg> </button> </div> <div data-nc-container="bottom-center"> </div> <div data-nc-container="bottom-right"> <a href="/search" class="Mobile-bar-search" data-nc-element="search-icon" aria-label="Search"> <svg class="Icon Icon--search" viewBox="0 0 20 20"> <use xlink:href="/assets/ui-icons.svg#search-icon"></use> </svg> </a> </div> </div> <div class="Mobile-overlay"> <div class="Mobile-overlay-menu" data-controller="MobileOverlayFolders"> <div class="Mobile-overlay-menu-main"> <nav class="Mobile-overlay-nav Mobile-overlay-nav--primary" data-content-field="navigation"> <a href="/" class="Mobile-overlay-nav-item"> Home </a> <button class="Mobile-overlay-nav-item Mobile-overlay-nav-item--folder" data-controller-folder-toggle="about-us-1"> <span class="Mobile-overlay-nav-item--folder-label">ABOUT US</span> </button> <button class="Mobile-overlay-nav-item Mobile-overlay-nav-item--folder" data-controller-folder-toggle="meetings-2"> <span class="Mobile-overlay-nav-item--folder-label">MEETINGS</span> </button> <a href="/support-1" class="Mobile-overlay-nav-item"> Support </a> <button class="Mobile-overlay-nav-item Mobile-overlay-nav-item--folder" data-controller-folder-toggle="awards-1"> <span class="Mobile-overlay-nav-item--folder-label">AWARDS</span> </button> <a href="/working-groups-1" class="Mobile-overlay-nav-item"> Working Groups </a> <a href="/academy" class="Mobile-overlay-nav-item"> CIMT Academy </a> <a href="/membership-jobs" class="Mobile-overlay-nav-item"> Membership </a> <a href="/contact-1" class="Mobile-overlay-nav-item"> Contact </a> </nav> <nav class="Mobile-overlay-nav Mobile-overlay-nav--secondary" data-content-field="navigation"> <button class="Mobile-overlay-nav-item Mobile-overlay-nav-item--folder" data-controller-folder-toggle="cip-3"> <span class="Mobile-overlay-nav-item--folder-label">//CIP</span> </button> <button class="Mobile-overlay-nav-item Mobile-overlay-nav-item--folder" data-controller-folder-toggle="rrg-3"> <span class="Mobile-overlay-nav-item--folder-label">//RRG</span> </button> </nav> </div> <div class="Mobile-overlay-folders" data-content-field="navigation"> <div class="Mobile-overlay-folder" data-controller-folder="about-us-1"> <button class="Mobile-overlay-folder-item Mobile-overlay-folder-item--toggle" data-controller-folder-toggle="about-us-1"> <span class="Mobile-overlay-folder-item--toggle-label">Back</span> </button> <a href="/who-we-are" class="Mobile-overlay-folder-item"> Who We Are </a> <a href="/20-years-of-cimt" class="Mobile-overlay-folder-item"> 20 Years of CIMT </a> <a href="/partners" class="Mobile-overlay-folder-item"> Partners </a> <a href="/annual-report-1" class="Mobile-overlay-folder-item"> Annual Report </a> <a href="/publications" class="Mobile-overlay-folder-item"> Publications </a> </div> <div class="Mobile-overlay-folder" data-controller-folder="meetings-2"> <button class="Mobile-overlay-folder-item Mobile-overlay-folder-item--toggle" data-controller-folder-toggle="meetings-2"> <span class="Mobile-overlay-folder-item--toggle-label">Back</span> </button> <a href="/meetings" class="Mobile-overlay-folder-item"> Annual Meeting </a> <a href="/cancer-cell-therapy-summit" class="Mobile-overlay-folder-item"> Cancer Cell Therapy Summit </a> <a href="/cicon" class="Mobile-overlay-folder-item"> CICON </a> <a href="/summer-school" class="Mobile-overlay-folder-item"> Summer School </a> <a href="/winter-school" class="Mobile-overlay-folder-item"> Winter School </a> <a href="/community" class="Mobile-overlay-folder-item"> Community </a> </div> <div class="Mobile-overlay-folder" data-controller-folder="awards-1"> <button class="Mobile-overlay-folder-item Mobile-overlay-folder-item--toggle" data-controller-folder-toggle="awards-1"> <span class="Mobile-overlay-folder-item--toggle-label">Back</span> </button> <a href="/lifetime-achievement" class="Mobile-overlay-folder-item"> Lifetime Achievement </a> <a href="/poster-awards" class="Mobile-overlay-folder-item"> Poster Awards </a> </div> <div class="Mobile-overlay-folder" data-controller-folder="cip-3"> <button class="Mobile-overlay-folder-item Mobile-overlay-folder-item--toggle" data-controller-folder-toggle="cip-3"> <span class="Mobile-overlay-folder-item--toggle-label">Back</span> </button> <a href="/news-1" class="Mobile-overlay-folder-item"> CIP News </a> <a href="/about-cip-1" class="Mobile-overlay-folder-item"> About CIP </a> <a href="/panels-and-workshops" class="Mobile-overlay-folder-item"> Panels and Workshops </a> <a href="/research" class="Mobile-overlay-folder-item"> Research </a> <a href="/cimt-annual-meeting" class="Mobile-overlay-folder-item"> CIMT meetings </a> <a href="/publications-1" class="Mobile-overlay-folder-item"> Publications </a> <a href="/participants" class="Mobile-overlay-folder-item"> Participants </a> <a href="/partners-supporters" class="Mobile-overlay-folder-item"> Partners & Supporters </a> <a href="/miata-1" class="Mobile-overlay-folder-item"> MIATA </a> </div> <div class="Mobile-overlay-folder" data-controller-folder="rrg-3"> <button class="Mobile-overlay-folder-item Mobile-overlay-folder-item--toggle" data-controller-folder-toggle="rrg-3"> <span class="Mobile-overlay-folder-item--toggle-label">Back</span> </button> <a href="/rrg-2" class="Mobile-overlay-folder-item"> About RRG </a> <a href="/members" class="Mobile-overlay-folder-item"> Members </a> <a href="/activities" class="Mobile-overlay-folder-item"> Activities </a> </div> </div> </div> <button class="Mobile-overlay-close" data-controller="MobileOverlayToggle" aria-label="Close navigation menu"> <svg class="Icon Icon--close" viewBox="0 0 16 16"> <use xlink:href="/assets/ui-icons.svg#close-icon"></use> </svg> </button> <div class="Mobile-overlay-back" data-controller="MobileOverlayToggle"></div> </div> </div> <div class="Parallax-host-outer"> <div class="Parallax-host" data-parallax-host> </div> </div> <div class="Site" data-nc-base="header" data-controller="AncillaryLayout"> <div class="sqs-announcement-bar-dropzone"></div> <header class="Header Header--top"> <div class="Header-inner Header-inner--top" data-nc-group="top"> <div data-nc-container="top-left"> <div class="Header-search" data-nc-element="search"> <form class="Header-search-form" action="/search" method="get"> <input class="Header-search-form-input" name="q" type="text" spellcheck="false" value="" autocomplete="off" placeholder="Search" /> <button class="Header-search-form-submit" type="submit" data-test="template-search"> <svg class="Icon Icon--search--small" viewBox="0 0 15 15"> <use xlink:href="/assets/ui-icons.svg#search-icon--small"></use> </svg> <svg class="Icon Icon--search" viewBox="0 0 20 20"> <use xlink:href="/assets/ui-icons.svg#search-icon"></use> </svg> </button> </form> </div> </div> <div data-nc-container="top-center"> </div> <div data-nc-container="top-right"> </div> </div> </header> <div class="Site-inner"> <header class="Header Header--bottom"> <div class="Header-inner Header-inner--bottom" data-nc-group="bottom"> <div data-nc-container="bottom-left"> <nav class="Header-nav Header-nav--primary" data-nc-element="primary-nav" data-content-field="navigation"> <div class="Header-nav-inner"> <a href="/" class="Header-nav-item" data-test="template-nav">Home</a><span class="Header-nav-item Header-nav-item--folder"> <a href="/about-us-1" class="Header-nav-folder-title" data-controller="HeaderNavFolderTouch">ABOUT US</a> <span class="Header-nav-folder"> <a href="/who-we-are" class="Header-nav-folder-item" data-test="template-nav">Who We Are</a> <a href="/20-years-of-cimt" class="Header-nav-folder-item" data-test="template-nav">20 Years of CIMT</a> <a href="/partners" class="Header-nav-folder-item" data-test="template-nav">Partners</a> <a href="/annual-report-1" class="Header-nav-folder-item" data-test="template-nav">Annual Report</a> <a href="/publications" class="Header-nav-folder-item" data-test="template-nav">Publications</a> </span> </span><span class="Header-nav-item Header-nav-item--folder"> <a href="/meetings-2" class="Header-nav-folder-title" data-controller="HeaderNavFolderTouch">MEETINGS</a> <span class="Header-nav-folder"> <a href="/meetings" class="Header-nav-folder-item" data-test="template-nav">Annual Meeting</a> <a href="/cancer-cell-therapy-summit" class="Header-nav-folder-item" data-test="template-nav">Cancer Cell Therapy Summit</a> <a href="/cicon" class="Header-nav-folder-item" data-test="template-nav">CICON</a> <a href="/summer-school" class="Header-nav-folder-item" data-test="template-nav">Summer School</a> <a href="/winter-school" class="Header-nav-folder-item" data-test="template-nav">Winter School</a> <a href="/community" class="Header-nav-folder-item" data-test="template-nav">Community</a> </span> </span><a href="/support-1" class="Header-nav-item" data-test="template-nav">Support</a><span class="Header-nav-item Header-nav-item--folder"> <a href="/awards-1" class="Header-nav-folder-title" data-controller="HeaderNavFolderTouch">AWARDS</a> <span class="Header-nav-folder"> <a href="/lifetime-achievement" class="Header-nav-folder-item" data-test="template-nav">Lifetime Achievement</a> <a href="/poster-awards" class="Header-nav-folder-item" data-test="template-nav">Poster Awards</a> </span> </span><a href="/working-groups-1" class="Header-nav-item" data-test="template-nav">Working Groups</a><a href="/academy" class="Header-nav-item" data-test="template-nav">CIMT Academy</a><a href="/membership-jobs" class="Header-nav-item" data-test="template-nav">Membership</a><a href="/contact-1" class="Header-nav-item" data-test="template-nav">Contact</a> </div> </nav> </div> <div data-nc-container="bottom-center"> <a href="/" class="Header-branding" data-nc-element="branding" data-content-field="site-title"> <img src="//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png" alt="CIMT" sizes="320px" class="Header-branding-logo" style="display:block" srcset="//images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=100w 100w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=300w 300w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=500w 500w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=750w 750w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=1000w 1000w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=1500w 1500w, //images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530810889238-2ZIO6TG6ZM8QDXL9MCGD/CIMT_Logo_weiss_150px.png?format=2500w 2500w" loading="lazy" decoding="async" data-loader="sqs"> </a> </div> <div data-nc-container="bottom-right"> <nav class="Header-nav Header-nav--secondary" data-nc-element="secondary-nav" data-content-field="navigation"> <div class="Header-nav-inner"> <span class="Header-nav-item Header-nav-item--folder"> <a href="/cip-3" class="Header-nav-folder-title Header-nav-folder-title--active" data-controller="HeaderNavFolderTouch">//CIP</a> <span class="Header-nav-folder"> <a href="/news-1" class="Header-nav-folder-item" data-test="template-nav">CIP News</a> <a href="/about-cip-1" class="Header-nav-folder-item" data-test="template-nav">About CIP</a> <a href="/panels-and-workshops" class="Header-nav-folder-item" data-test="template-nav">Panels and Workshops</a> <a href="/research" class="Header-nav-folder-item" data-test="template-nav">Research</a> <a href="/cimt-annual-meeting" class="Header-nav-folder-item" data-test="template-nav">CIMT meetings</a> <a href="/publications-1" class="Header-nav-folder-item Header-nav-folder-item--active" data-test="template-nav">Publications</a> <a href="/participants" class="Header-nav-folder-item" data-test="template-nav">Participants</a> <a href="/partners-supporters" class="Header-nav-folder-item" data-test="template-nav">Partners & Supporters</a> <a href="/miata-1" class="Header-nav-folder-item" data-test="template-nav">MIATA</a> </span> </span><span class="Header-nav-item Header-nav-item--folder"> <a href="/rrg-3" class="Header-nav-folder-title" data-controller="HeaderNavFolderTouch">//RRG</a> <span class="Header-nav-folder"> <a href="/rrg-2" class="Header-nav-folder-item" data-test="template-nav">About RRG</a> <a href="/members" class="Header-nav-folder-item" data-test="template-nav">Members</a> <a href="/activities" class="Header-nav-folder-item" data-test="template-nav">Activities</a> </span> </span> </div> </nav> </div> </div> </header> <div class="Content-outer"> <main class="Main Main--page" > <section class="Main-content" data-content-field="main-content"> <div class="sqs-layout sqs-grid-12 columns-12" data-type="page" data-updated-on="1553507471355" id="page-5b6c309e8a922d23fb11ab49"><div class="row sqs-row"><div class="col sqs-col-3 span-3"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-cd070fbbc66ddee96398"><div class="sqs-block-content"> </div></div></div><div class="col sqs-col-6 span-6"><div class="row sqs-row"><div class="col sqs-col-5 span-5"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-yui_3_17_2_1_1534414225274_21100"><div class="sqs-block-content"> </div></div></div><div class="col sqs-col-1 span-1"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-169e0a2abd3d126604ef"><div class="sqs-block-content"> </div></div></div></div><div class="sqs-block code-block sqs-block-code" data-block-type="23" id="block-yui_3_17_2_1_1534855911161_27587"><div class="sqs-block-content"><p id="publications-and-communications"><h1 id_"yui_3_17_2_1_1530605964027_1149">Publications and Communications</h1></p> </div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1534855911161_27654"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">Guidelines and Protocols</h2><p style="white-space:pre-wrap;">An <a href="/s/cip_guidelines.pdf" target="_blank"><strong>assay guideline</strong></a> document is available which presents crucial issues for assay performance (ELISPOT, HLA-multimers) based on CIP proficiency panel experience and results.</p><p style="white-space:pre-wrap;">Exemplary protocol for <a href="/s/cip_hla.pdf" target="_blank"><strong>HLA-multimer staining</strong></a> (March 2011)</p><p style="white-space:pre-wrap;"><a href="/s/sop_elispot.pdf" target="_blank"><strong>SOP for ELISPOT</strong></a> assay without serum, kindly provided by a high performer lab (March 2011)</p><p style="white-space:pre-wrap;">Recommendations for <a href="/s/CIP-Storage-MHCmultimers.pdf" target="_blank"><strong>long-term storage of MHC-multimer by freezing </strong></a>(Hadrup et al. Cytometry A, 87:37, 2015)</p><p style="white-space:pre-wrap;">Guideline for <a href="https://www.nature.com/articles/nprot.2015.068" target="_blank"><strong>Elispot plate reading</strong></a> (Janetzki et al. Nat Protocols 10:1098, 2015)</p><p style="white-space:pre-wrap;">Consensus <strong>Ab panel for Treg detection</strong> (Santegoets et al. Cancer Immunol Immunother 64:1271-86, 2015) and <a href="/s/CD127-Ab-comparison-for-Treg-staining_For-CIP-homepage.pdf" target="_blank"><strong>comparison of Abs for CD127 staining</strong></a><strong> </strong>(2018) </p><p style="white-space:pre-wrap;">Harmonized<strong> </strong><a href="/s/GAPVAC-TIL-protocol_CIP-homepage.pdf" target="_blank"><span style="text-decoration:underline"><strong>protocol for TILs isolation and expansion</strong></span> </a>(Hilf et al. Nature 565:240-45, 2019)</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_68854"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_68915"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">Reports from Proficiency Panels</h2><p style="white-space:pre-wrap;">Are available upon request:</p><p style="white-space:pre-wrap;"><strong>Report CIP_ID18_2013_NK/E </strong>(phenotype and function of NK cells, -Feb 2014-)<br><strong>Report CIP_ID15_2012_ELI/S </strong>(service panel, Elispot assay - Nov 2014-)<br><strong>Report CIP_ID14_2012_ELIMUL/E </strong>(ELISPOT and HLA-multimer staining for in vitro expanded cells, 2nd phase ID11 -Dec 2012-)<br><strong>Report CIP_ID13_2011_MUL/D </strong>(Multicolor HLA-multimer staining, 2nd phase of ID07 -Jan 2013-)<br><strong>Report CIP_ID11_2011_ELIMUL/E </strong>(ELISPOT and HLA-multimer staining for in vitro expanded cells -April 2012-)<br><strong>Report CIP_ID09_2010_ELI/S</strong> (ELISPOT -June 2011-)<br><strong>Report CIP_ID08_2010_GAT/D</strong> (intracellular cytokine staining, gating -March 2011-)<br><strong>Report CIP_ID07_2010_MUL/D</strong> (HLA-multimers -Oct 2010-)<br><strong>Report CIP_ID06_2009_ICS/D</strong> (intracellular cytokine staining -March 2011-)<br><strong>Report CIP_ID05_2008_ICS/D</strong> (intracellular cytokine staining -July 2009-)<br><strong>Report CIP_ID04_2008_ELI/S</strong> (ELISPOT -Aug 2008-)<br><strong>Report CIP_ID03_2008_MUL/S</strong> (HLA-multimers -Sept 2008-)<br><strong>Report CIP_ID02_2006_ELIMUL/S</strong> (ELISPOT and HLA-multimers -Nov 2006-)<br><strong>Report CIP_ID01_2005_ELIMUL/S</strong> (ELISPOT and HLA-multimers -Oct 2005-)</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_79739"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_79799"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">Original Articles</h2><p style="white-space:pre-wrap;">Hilf N,Hilf N, Kuttruff-Coqui S, […], Wick W. <strong>Actively personalized vaccination trial for newly diagnosed glioblastoma.</strong> <em>Nature. </em>2019.<em> </em>565:240-245. </p><p style="white-space:pre-wrap;">Chandran PA, Laske K, Cazaly A, Rusch E, Schmid-Horch B, Rammensee HG, Ottensmeier CH, Gouttefangeas C. <strong>Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay. </strong> <em>Cytometry B Clin Cyto</em>. 2018 Mar;94(2):342-353. <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/cyto.b.21397">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=27363684">PMID.</a></p><p style="white-space:pre-wrap;">Bidmon N, Kind S, Welters MJP, Joseph-Pietras D, Laske K, Maurer D, Hadrup SR, Schreibelt G, Rae R, Sahin U, Gouttefangeas C, Britten CM, van der Burg SH. <strong>Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance</strong>. <em>J. Immunol. Methods</em>. <strong>2018</strong>. 458:74-82. <a href="https://doi.org/10.1016/j.jim.2018.04.007">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/29684430">PMID</a>. </p><p style="white-space:pre-wrap;">Pedersen NW, Chandran PA, Qian Y, Rebhahn J, Petersen NV, Hoff MD, White S, Lee AJ, Stanton R, Halgreen C, Jakobsen K, Mosmann T, Gouttefangeas C, Chan C, Scheuermann RH, Hadrup SR. <strong>Automated Analysis of Flow Cytometry Data to Reduce Inter-Lab Variation in the Detection of Major Histocompatibility Complex Multimer-Binding T Cells.</strong> <em>Front. Immunol</em>. <strong>2017</strong>. 8:858. <a href="https://doi.org/10.3389/fimmu.2017.00858">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/28798746">PMID</a>.</p><p style="white-space:pre-wrap;">Mandruzzato S, Brandau S, Britten CM, Bronte V, Damuzzo V, Gouttefangeas C, Maurer D, Ottensmeier C, van der Burg SH, Welters MJ, Walter S. <strong>Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2016</strong>. 65:161-9. <a href="https://doi.org/10.1007/s00262-015-1782-5">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26728481">PMID</a>.</p><p style="white-space:pre-wrap;">Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH. <strong>Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2015</strong>. 64:1271-86. <a href="https://doi.org/10.1007/s00262-015-1729-x">DOI.</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/26122357">PMID</a>. </p><p style="white-space:pre-wrap;">Janetzki S, Price L, Schroeder H, Britten CM, Welters MJ, Hoos A. <strong>Guidelines for the automated evaluation of Elispot assays.</strong> <em>Nat. Protoc</em>. <strong>2015</strong>. 10:1098-115. <a href="https://doi.org/10.1038/nprot.2015.068">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26110715">PMID</a>. </p><p style="white-space:pre-wrap;">Bidmon N, Attig S, Rae R, Schröder H, Omokoko TA, Simon P, Kuhn AN, Kreiter S, Sahin U, Gouttefangeas C, van der Burg SH, Britten CM. <strong>Generation of TCR-engineered T cells and their use to control the performance of T cell assays</strong>. J<em>. Immunol</em>. <strong>2015</strong>. 194:6177-89. <a href="https://doi.org/10.4049/jimmunol.1400958">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25957167">PMID</a> </p><p style="white-space:pre-wrap;">White S, Laske K, Welters MJ, Bidmon N, van der Burg SH, Britten CM, Enzor J, Staats J, Weinhold KJ, Gouttefangeas C, Chan C. <strong>Managing Multi-center Flow Cytometry Data for Immune Monitoring. </strong><em>Cancer Inform</em>. <strong>2015</strong>. 13:111-22. <a href="https://doi.org/10.4137/CIN.S16346">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26085786">PMID</a>. </p><p style="white-space:pre-wrap;">Gouttefangeas C, Chan C, Attig S, Køllgaard TT, Rammensee HG, Stevanović S, Wernet D, thor Straten P, Welters MJ, Ottensmeier C, van der Burg SH, Britten CM. <strong>Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2015</strong>. 64:585-98. <a href="https://doi.org/10.1007/s00262-014-1649-1">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25854580">PMID</a>.</p><p style="white-space:pre-wrap;">Hadrup SR, Maurer D, Laske K, Frøsig TM, Andersen SR, Britten CM, van der Burg SH, Walter S, Gouttefangeas C. Cryopreservation of MHC multimers: <strong>Recommendations for quality assurance in detection of antigen specific T cells. </strong><em>Cytometry A</em>. <strong>2015</strong>. 87:37-48. <a href="https://doi.org/10.1002/cyto.a.22575">DOI.</a> <a href="https://www.ncbi.nlm.nih.gov/pubmed/25297339">PMID</a>. </p><p style="white-space:pre-wrap;">Chudley L, McCann KJ, Coleman A, Cazaly AM, Bidmon N, Britten CM, van der Burg SH, Gouttefangeas C, Jandus C, Laske K, Maurer D, Romero P, Schröder H, Stynenbosch LF, Walter S, Welters MJ, Ottensmeier CH. <strong>Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2014</strong>. 63:1199-211. <a href="https://doi.org/10.1007/s00262-014-1593-0">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25134947">PMID</a>.</p><p style="white-space:pre-wrap;">Cron A, Gouttefangeas C, Frelinger J, Lin L, Singh SK, Britten CM, Welters MJ, van der Burg SH, West M, Chan C. <strong>Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples.</strong> <em>PLoS Comput. Biol</em>. <strong>2013</strong>. 9:e1003130. <a href="https://doi.org/10.1371/journal.pcbi.1003130">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+23874174">PMID</a> </p><p style="white-space:pre-wrap;">Filbert H, Attig S, Bidmon N, Renard BY, Janetzki S, Sahin U, Welters MJP, Ottensmeier C, van der Burg SH, Gouttefangeas C, Britten CM.<strong> Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2012</strong>. 62:615-627. <a href="https://dx.doi.org/10.1007/s00262-012-1359-5">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/23138872">PMID</a>. </p><p style="white-space:pre-wrap;">Singh SK, Tummers B, Schumacher TN, Gomez R, Franken KL, Verdegaal EM, Laske K, Gouttefangeas C, Ottensmeier C, Welters MJ, Britten CM, van der Burg SH. <strong>The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2012</strong>. 62:389-501. <a href="https://doi.org/10.1007/s00262-012-1351-0">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22986454">PMID</a>.</p><p style="white-space:pre-wrap;">Singh SK, Meyering M, Ramwadhdoebe TH, Stynenbosch LF, Redeker A, Kuppen PJ, Melief CJ, Welters MJ, van der Burg SH. <strong>The simultaneous <em>ex vivo</em> detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools. </strong><em>Cancer Immunol. Immunother.</em> <strong>2012</strong>. 61:1953-1963. <a href="https://doi.org/10.1007/s00262-012-1251-3">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22491788">PMID</a>. </p><p style="white-space:pre-wrap;">Welters MJ, Gouttefangeas C, Ramwadhdoebe TH, Letsch A, Ottensmeier CH, Britten CM, van der Burg SH. <strong>Harmonization of the intracellular cytokine staining assay.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2012</strong>. 61:967-978. <a href="https://dx.doi/org/10.1007/s00262-012-1282-9">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22714399">PMID</a>. </p><p style="white-space:pre-wrap;">Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Löwer M, Welters MJ, Ottensmeier C, van der Burg SH, Britten CM. <strong>Response definition criteria for ELISPOT assays revisited.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2010</strong>. 59:1489-501. <a href="https://doi.org/10.1007/s00262-010-0875-4">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/%2020549207">PMID</a> </p><p style="white-space:pre-wrap;">Mander A, Gouttefangeas C, Ottensmeier C, Welters MJ, Low L, van der Burg SH, Britten CM. <strong>Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2010</strong>. 59:619-27. <a href="https://doi.org/10.1007/s00262-009-0814-4">DOI</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20052465">PMID</a>. </p><p style="white-space:pre-wrap;">Janetzki, S., Price, L., Britten, C. M., van der Burg, S. H., Caterini, J., Currier, J. R., Hoos, A. <strong>Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells.</strong> <em>Cancer Immunology, Immunotherapy. 2010.</em>, <em>59</em>(4), 609–618. <a href="http://doi.org/10.1007/s00262-009-0788-2">DOI.</a></p><p style="white-space:pre-wrap;">Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Müller-Berghaus J, Haas I, Mackensen A, Køllgaard T, thor Straten P, Schmitt M, Giannopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanović S, Wölfel T, van der Burg SH. <strong>The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2008</strong>. 57:289-302. <a href="https://doi.org/10.1007/s00262-007-0378-0">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/17721783">PMID</a>. </p><p data-rte-preserve-empty="true" style="white-space:pre-wrap;"></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_113517"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block code-block sqs-block-code" data-block-type="23" id="block-yui_3_17_2_1_1533817010292_297051"><div class="sqs-block-content"><a href="#" class="btt">↑</a></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_113577"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">Comments / letters / reviews / book chapters</h2><p style="white-space:pre-wrap;">Britten CM, van der Burg SH, Gouttefangeas C.<strong> A framework for T cell assays. </strong><em>Oncotarget</em>.<strong> 2015. </strong>6:35143-4. <a href="https://doi.org/10.18632/oncotarget.6181">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26506424">PMID</a>. </p><p style="white-space:pre-wrap;">Kvistborg P, Gouttefangeas C, Aghaeepour N, Cazaly A, Chattopadhyay PK, Chan C, Eckl J, Finak G, Hadrup SR, Maecker HT, Maurer D, Mosmann T, Qiu P, Scheuermann RH, Welters MJ, Ferrari G, Brinkman RR, Britten CM<strong>. Thinking outside the gate: single-cell assessments in multiple dimensions. </strong><em>Immunity</em>.<strong> 2015. </strong>42:591-2. <a href="https://doi.org/10.1016/j.immuni.2015.04.006">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25902473">PMID</a>.</p><p style="white-space:pre-wrap;">Gouttefangeas C, Walter S, Welter MJP, Ottensmeier CH, van der Burg SH, Britten CM, Chan C. <strong>Flow Cytometry in Cancer Immunotherapy: Applications, Quality Assurance and Future.</strong><em> </em> <em>Cancer Immunology: Translational Medicine from Bench to Bedside</em> (ed. N Rezaei). Springer. Chapter 25: 471-486. <strong>2015</strong>.</p><p style="white-space:pre-wrap;">van der Burg SH, Walter S, Janetzki S, Britten CM, Galon J, Welters MJP, Gouttefangeas C <strong>Immunoguiding, the final frontier in the immunotherapy of cancer.</strong> (2014) In Cancer Immunotherapy meets oncology (CM Britten, S Kreiter, M. Diken & HG Rammensee eds). Springer International Publishing Switzerland p37-51 ISBN: 978-3-319-05103-1</p><p style="white-space:pre-wrap;">Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJM, O’Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff THM, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM. <strong>T Cell Assays and MIATA: The Essential Minimum for Maximum Impact</strong> Immunity 2012 Jul;37(1):37:1-2</p><p style="white-space:pre-wrap;">Fox BA, et al. <strong>Defining the critical hurdles in cancer immunotherapy. </strong><em>J. Transl. Med.</em><strong> 2011. </strong>9:214. <a href="https://doi.org/10.1186/1479-5876-9-214">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22168571">PMID</a>.</p><p style="white-space:pre-wrap;">van der Burg SH, Kalos M, Gouttefangeas C, Janetzki S, Ottensmeier C, Welters MJP, Romero P, Britten CM, Hoos A. <strong>Harmonization of immune biomarker assays for clinical studies.</strong> <em>Sci. Transl. Med</em>. <strong>2011</strong>. 3:108ps44. <a href="https://doi.org/10.1126/scitranslmed.3002785">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22072636">PMID</a>.</p><p style="white-space:pre-wrap;">Britten CM, Janetzki S, Gouttefangeas C, Welters MJ, Kalos M, Ottensmeier CH, Hoos A, van der Burg SH. <strong>T-cell immune monitoring assays to guide the development of new cancer vaccines.</strong> In Cancer Vaccines: From Research to Clinical Practice, by Adrian Bot, Mihail Obrocea, Francesco Marincola, C. Ed Informa Healthcare. September 2011</p><p style="white-space:pre-wrap;">Britten CM, Janetzki S, van der Burg SH, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJM, O’Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM. <strong>Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2011</strong>. 60:15–22. <a href="https://doi.org/10.1007/s00262-010-0940-z">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21080166">PMID</a>.</p><p style="white-space:pre-wrap;">Frelinger J, Ottinger J, Gouttefangeas C, Chan C. <strong>Modeling flow cytometry data for cancer vaccine immune monitoring. </strong><em>Cancer Immunol Immunother</em>. 2010. 59:1435-41. DOI. <a href="https://www.ncbi.nlm.nih.gov/pubmed/20563720">PMID</a>..</p><p style="white-space:pre-wrap;">Janetzki S, Britten CM, Kalos M, Levitsky HI, Maecker HT, Melief CJ, Old LJ, Romero P, Hoos A, Davis MM. <strong>MIATA: Minimal Information About T cell Assays. </strong><em>Immunity</em>.<strong> 2009. </strong>31:527‐28. <a href="https://doi.org/10.1016/j.immuni.2009.09.007">DOI</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19833080">PMID</a><strong>.</strong></p><p style="white-space:pre-wrap;">Britten CM, Janetzki S, van der Burg SH, Gouttefangeas C, Hoos A. <strong>Toward the harmonization of immune monitoring in clinical trials: Quo vadis?</strong> <em>Cancer Immunol. Immunother.</em> <strong>2008</strong>. 57:285-8. <a href="https://doi.org/10.1007/s00262-007-0379-z">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/17721782">PMID</a>. <br> A full text version of the article is available via <a href="http://www.springerlink.com/content/p8975670262226nr/fulltext.pdf" target="_blank">Springer</a></p><p style="white-space:pre-wrap;">van der Burg SH. <strong>Therapeutic Vaccines in Cancer, Moving from Immunomonitoring to Immunoguiding.</strong> <em>Expert Review of Vaccines.</em> <strong>2008</strong>. 7:1-5. <a href="https://doi.org/10.1586/14760584.7.1.1">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/18251686">PMID</a>.</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_140429"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block code-block sqs-block-code" data-block-type="23" id="block-yui_3_17_2_1_1533817010292_293377"><div class="sqs-block-content"><a href="#" class="btt">↑</a></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_140489"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">CIMT Meeting Reports</h2><p style="white-space:pre-wrap;">Diken M, Chu KK, Brodsky AN. <strong>Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference</strong>. <em>Cancer Immunol. Res</em>. <strong>2018</strong>. 6:10-13. <a href="https://doi.org/10.1158/2326-6066.CIR-17-0656">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/29298782">PMID</a>.</p><p style="white-space:pre-wrap;">Kranz LM, Birtel M, Hilscher L, Grunwitz C, Petschenka J, Vascotto F, Vormehr M, Voss RH, Kreiter S, Diken M. <strong>CIMT 2016: Mechanisms of efficacy in cancer research – Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy.</strong> May 10-12, 2016, Mainz, Germany. <em>Hum. Vaccin. Immunother</em>. <strong>2016</strong>. 12:2805-12. <a href="https://doi.org/10.1080/21645515.2016.1206677">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27435168">PMID</a> </p><p style="white-space:pre-wrap;">Miller M, Jahndel V, Kutscher S, Mahr A, Rae R, Kloke BP. T<strong>he right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany</strong>, May 11-13, 2015. <em>Cancer Immunol. Immunother</em>. <strong>2016</strong>. 65:1277-87. <a href="https://doi.org/10.1007/s00262-016-1850-5">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27259506">PMID</a>.<br><br>Kranz L, Birtel M, Krienke C, Grunwitz C, Petschenka J, Reuter K, van de Roemer N, Vascotto F, Vormehr M, Kreiter S, Diken M. <strong>CIMT 2015: The right patient for the right therapy - Report on the 13th Annual Meeting of the Association for Cancer Immunotherapy.</strong> <em>Hum. Vaccin. Immunother</em>. <strong>2015</strong>. 12:213-21. <a href="https://doi.org/10.1080/21645515.2015.1068485">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26186022">PMID</a>.</p><p style="white-space:pre-wrap;">Diken M, Boegel S, Grunwitz C, Kranz L, Reuter K, van de Roemer N, Vascotto F, Vormehr M, Kreiter S. CIMT 2014: <strong>Next waves in cancer immunotherapy - report on the 12th annual meeting of the Association for Cancer Immunotherapy.</strong> <em>Hum. Vaccin. Immunother</em>. 2015. 10:3090-100. <a href="https://doi.org/10.4161/hv.29767">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25483671">PMID</a>.</p><p style="white-space:pre-wrap;">Kloke BP, Mahr A, Jabulowsky RA, Kutscher S, Rae R, Britten CM.<strong> Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.</strong> <em>Cancer Immunol. Immunother</em>. <strong>2014</strong>. 64:923-30. <a href="https://doi.org/10.1007/s00262-014-1643-7">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25548093">PMID</a>.</p><p style="white-space:pre-wrap;">Kloke BP, Rae R, Mahr A, Burkhardt UE, Kvistborg P, Britten CM. <strong>Towards the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2013</strong>. 63:749-55. <a href="https://doi.org/10.1007/s00262-013-1495-6">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/24190545">PMID</a>. </p><p style="white-space:pre-wrap;">Hobohm K, Seppmann T, Britten CM, Hoff H. <strong>Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2012</strong>. 61:137-43. <a href="https://doi.org/10.1007/s00262-011-1131-2">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22048716">PMID</a> 7</p><p style="white-space:pre-wrap;">Singh SK, Laske K, Gouttefangeas C, Britten CM, Welters MJ. <strong>CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2011</strong>. 60:443-50. <a href="https://doi.org/10.1007/s00262-010-0947-5">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21104411">PMID</a>. </p><p style="white-space:pre-wrap;">Diken M, Widenmeyer M, Gouttefangeas C, Welters MJ, Britten CM.<strong> CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2010</strong>. 59:1417-23. <a href="https://doi.org/10.1007/s00262-009-0770-z">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/19771427">PMID</a>. </p><p style="white-space:pre-wrap;"> Welters MJ, van Montfoort N, Khan S, Meyer RG, Britten CM. <strong>Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2009</strong>. 58:777-87. <a href="https://doi.org/10.1007/s00262-008-0614-2">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/18982325">PMID</a>.</p><p style="white-space:pre-wrap;">Welters MJ, Gouttefangeas C, Attig S, Koch S, Britten CM. <strong>Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12-14, 2007 in Würzburg, Germany</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2008</strong>. 57:135-42. <a href="https://doi.org/10.1007/s00262-007-0408-y">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/17922124">PMID</a>.</p><p style="white-space:pre-wrap;">Gouttefangeas C, Britten CM, Badalians ED, Pawelec G. <strong>CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2007</strong>. 56:397-427. <a href="https://doi.org/10.1007/s00262-006-0211-1">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/16902797">PMID</a>. </p><p style="white-space:pre-wrap;"> Britten CM, Gouttefangeas C, Kreiter S. <strong>Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2006</strong>. 55:475-80. <a href="https://doi.org/10.1007/s00262-005-0059-9">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/16193336">PMID</a>.</p><p style="white-space:pre-wrap;"> Britten CM, Mueller L, Knights A, Pawelec G. <strong>Cancer Immunotherapy 2004: Mainz, Germany, 6-7 May 2004</strong>. <em>Cancer Immunol. Immunother</em>. <strong>2004</strong>. 53:1153-8. <a href="https://doi.org/10.1007/s00262-004-0580-2">DOI</a>. <a href="https://www.ncbi.nlm.nih.gov/pubmed/15340765">PMID</a>.</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_161799"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block code-block sqs-block-code" data-block-type="23" id="block-yui_3_17_2_1_1533817010292_289744"><div class="sqs-block-content"><a href="#" class="btt">↑</a></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_161859"><div class="sqs-block-content"> <div class="sqs-html-content"> <h2 style="white-space:pre-wrap;">Meetings</h2><h3 style="white-space:pre-wrap;"><strong>2016</strong></h3><p style="white-space:pre-wrap;"><strong>2nd Symposium on Advances in Cancer Immunology and Immunotherapy</strong>, 15-17 December 2016, Athens, Greece</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_106740"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_90170"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2015</h3><p style="white-space:pre-wrap;"><strong>CIP in the European 7th framework project GAPVAC</strong> 27 October 2015, Mainz, Germany</p><p style="white-space:pre-wrap;"><strong>CIP at the annual AACR meeting </strong>18-22 April 2015, Philadelphia, USA</p><p style="white-space:pre-wrap;"><strong>4th Cancer Immunotherapy and Immunomonitoring Conference (CITIM)</strong> 27–30 April 2015, Ljubljana, Slovenia – Oral presentation – Harmonization of immunomonitoring assays: the CIP experience</p><p style="white-space:pre-wrap;"><strong>CIP in the European 7th framework project GAPVAC</strong> 27 October 2015, Mainz, Germany</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_87097"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_87157"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2014</h3><p style="white-space:pre-wrap;"><strong>European Research Infrastructures for Poverty Related Diseases</strong>, November 17, 2014 – Oral presentation – Harmonization of the ICS and its application in immunotherapy of cancer patients</p><p style="white-space:pre-wrap;"><strong>29th SITC Annual Meeting</strong>, November 7-9, 2014, National Harbor MD – Poster – Detection and functional assessment of regulatory T-cells in clinical samples</p><p style="white-space:pre-wrap;"><strong>44rd Annual Meeting of the German Society for Immunology, </strong>September 17-20, 2014, Bonn, Germany – Joined satellite symposium CIMT-DGfI – Immune monitoring, new developments</p><p style="white-space:pre-wrap;"><strong>CYTO2014, May 17-21, 2014</strong>, Ft. Lauderdale, Florida<strong> </strong>– Oral presentation – Thinking out of the gate</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_82668"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_82728"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2013</h3><p style="white-space:pre-wrap;"><strong>13th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2013)</strong>, June 27-30, 2013, Boston, USA – Oral presentation – <em>Cancer Immunotherapy Immunoguiding Program Update</em><br><br><strong>CIC Scientific Colloquium “Entering the Era of Combination Therapies: Practical Implementation”</strong> April 25-27, 2013, Washington, USA – CIMT co-organization of Session 6: Immune monitoring <em>– Oral presentations -</em><br><br><strong>3rd Cancer Immunotherapy and Immunomonitoring Conference (CITIM)</strong> April 22-25, 2013, Poland – Poster – <em>The Cancer Immunotherapy Immunoguiding Program (CIP): An international network for harmonizing immunological biomarkers in cancer immunotherapy</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_78210"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_78270"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2012</h3><p style="white-space:pre-wrap;"><strong>20th Meeting DNA vaccines 2012</strong>, December 5-7, 2012, San Diego, USA – Oral presentation – <em>Update on CIP and MIATA</em></p><p style="white-space:pre-wrap;"><strong>Progress in Vaccination Against Cancer, PIVAC 12 meeting</strong>, September, 11-13 2012, Nottingham, UK – Poster -The Cancer Immunotherapy Immunoguiding Program (CIP): An international network for the harmonization of immune monitoring assays</p><p style="white-space:pre-wrap;"><strong>CIC Scientific Colloquium “ immune signatures in the tumor and beyond: toward predictive and prognostic markers”</strong> April 19-21, 2012, National Harbor, USA- Oral presentation – <em>Harmonizing immune monitoring T-cell assays, from cell samples to data analysis: recent proficiency panels of the Cancer Immunotherapy Immunoguiding Program (CIP)</em></p><p style="white-space:pre-wrap;"><strong>27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)</strong> October 26-28, 2012, North Bethesda, USA – Poster<em> – Harmonization of immunological biomarkers by an international network: the Cancer Immunotherapy Immunoguiding Program (CIP)</em></p><p style="white-space:pre-wrap;"><strong>40th congress of the International Society of Oncology and Biomarkers (ISOBM) </strong>October 13-17, 2012, Jerusalem, Israel – Oral presentation -. <em>The Cancer Immunotherapy Immunoguiding Program (CIP):An international network for the harmonization of cellular immunological biomarkers</em></p><p style="white-space:pre-wrap;"><strong>CIC Scientific Colloquium, Immune signatures in the tumor and beyond: toward predictive and prognostic markers”</strong> April 19-21, 2012, National Harbor, USA- Oral presentation – <em>Harmonizing immune monitoring T-cell assays, from cell samples to data analysis: recent proficiency panels of the Cancer Immunotherapy Immunoguiding Program (CIP)</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_73698"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_73758"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2011</h3><p style="white-space:pre-wrap;"><strong>ESCII/<em>NIBIT</em> Meeting</strong> <strong>New Perspectives in the Immunotherapy of Cancer,</strong> October 19-22, 2011, Siena, Italy – Oral presentation – <em>Harmonization of immune biomarker assays - Towards enhanced quality and reproducibility in clinical studies</em></p><p style="white-space:pre-wrap;"><strong><em>P</em>rogress in Vaccination Against Cancer, PIVAC 11 meeting</strong>, October 10-13, 2011, Copenhagen, Denmark – Poster -<em> The Cancer Immunotherapy Immunoguiding Program (CIP): </em>an international network for the harmonization of immune monitoring T-cell assays</p><p style="white-space:pre-wrap;"><strong>CIMT Annual Meeting</strong>, May 25- 27, 2011, Mainz, Germany – Oral presentations – “CIP break-out session”</p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1537436773025_66217"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537436773025_66277"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2010</h3><p style="white-space:pre-wrap;"><strong>Progress in Vaccination Against Cancer, PIVAC 10 meeting, </strong>September 27–30, 2010, Cambridge, UK – Oral presentation –<em> “Harmonisation of T-cell assays for the monitoring of immunotherapeutic trials: update on the CIMT Immunoguiding program”</em></p><p style="white-space:pre-wrap;"><strong>Biological Therapy of Cancer –from disease to targeted therapy</strong> 10th international symposium, September 8-10, 2010, Munich, Germany – Oral presentation<em> – “Monitoring and immunoguiding of clinical vaccine trials”</em></p><p style="white-space:pre-wrap;"><strong>CIMT Annual Meeting</strong>, May 26-28, 2010, Mainz, Germany – Oral presentations – <em>“CIP short talk session”</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_461550"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_461610"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2009</h3><p style="white-space:pre-wrap;"><strong>iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer</strong>, October 28, 2009, Washington D.C., USA – Short oral introduction to – <em>“The Cancer Immunotherapy Immunoguiding Program” </em></p><p style="white-space:pre-wrap;"><strong>EORTC-GI group – Perspectives of Immunotherapy in GI cancer</strong>, October 15-16, 2009, Amsterdam, The Netherlands – Oral presentation – <em>“Harmonized T-cell monitoring assays for immunotherapy trials”</em></p><p style="white-space:pre-wrap;"><strong>Progress in Vaccination Against Cancer, PIVAC 9 meeting</strong>, October 8–10, 2009, Sofia, Bulgaria – Oral presentation – <em>“Harmonized T-cell monitoring assays for immunotherapy trials. Update on the CIMT Immunoguiding Program”</em></p><p style="white-space:pre-wrap;"><strong>CIMT</strong>, June 3-5, 2009, Mainz, Germany – Oral presentations – <em>CIP late break-out session: new and ongoing panels (Multimers, ELISPOT, ICS) </em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_475650"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_475710"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2008</h3><p style="white-space:pre-wrap;"><strong>Joint ESCII Annual Meeting and PIVAC 8 meeting</strong> – Recent advances in cancer immunotherapy with an emphasis on cancer, October 9-10, 2008, Athens, Greece – Oral presentation – <em>“Harmonisation of T-cell monitoring: Report on the activities of the CIMT monitoring panel initiative”</em></p><p style="white-space:pre-wrap;"><strong>Cellular Mediated Immunity (CMI) standardization techniques in evaluation of vaccine response</strong>, September 15–17, 2008, Annency, France – Oral presentation – <em>“Harmonization of T cell immunomonitoring within the CIMT Monitoring Panel – correct protocol choices and additional sources of variation”</em></p><p style="white-space:pre-wrap;"><strong>Annual Meeting of the Cancer Reserch Institute: Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug</strong>, September 15-17, 2008, New York, USA – Oral presentation – <em>“Harmonized T-cell monitoring assays as biomarkers for immunotherapy trials: a data driven approach by the CIMT Immunoguiding program (CIP)“</em></p><p style="white-space:pre-wrap;"><strong>9th International Conference on Chronic Myeloid and Lymphoid Malignancies</strong>, May 29-31, 2008, Kazimierz Dolny, Poland – Oral presentation – <em>“Standardization of T cell immunomonitoring – protocol choices and additional sources of variation”</em></p><p style="white-space:pre-wrap;"><strong>CIMT Annual Meeting</strong>, May 15 -16, 2008, Mainz, Germany – Oral presentations – <em>“Updates on the CIMT immunomonitoring panel III (Multimers), panel IV (ELISPOT) and panel V (ICS)”</em></p><p style="white-space:pre-wrap;"><strong>9th International Symposium Biological Therapy of Cancer / From Disease to Targeted Therapy</strong>, March 12-15 2008, Munich, Germany – Oral presentation – <em>“Standardization of T-cell immunomonitoring – correct protocol choices and additional sources of variation”</em></p><p style="white-space:pre-wrap;"><strong>MASIR 2008 – Measurement of Antigen-Specific Immune Responses</strong>, January 30 - February 2, 2008, La Plagne, France – Oral presentation – <em>“The CIMT-Monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes”</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_486707"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_486767"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2007</h3><p style="white-space:pre-wrap;"><strong>DC Thera Immunomonitoring Workshop</strong>, December 6-7, 2007, Brussels, Belgium – Oral presentations – <em>“The CIMT-Monitoring panel: efforts towards the harmonization of T-cell monitoring”</em><br><em>Part 1: Harmonizing/Optimizing assay protocols</em><br><em>Part 2: Harmonization of additional aspects needed?</em></p><p style="white-space:pre-wrap;"><strong>Cancer Vaccines Adjuvants & Delivery Systems – CVADD 2007 Conference</strong>, October 10-12, 2007, Heidelberg, Germany – Oral presentation – <em>“The CIMT-Monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes”</em></p><p style="white-space:pre-wrap;"><strong>CVC Colloquium and Annual Meeting</strong>, September 27-29, 2007, Washington, USA – Oral presentation – <em>“First Harmonization Criteria for Cellular Immune Response Assays for Cancer Vaccine Trials – Results from Two Large Proficiency Panels”</em></p><p style="white-space:pre-wrap;"><strong>CIMT Annual Meeting</strong>, April 12-14, 2007, Würzburg, Germany – Oral presentation – <em>“Lessons learned from interlaboratory testing in phases I/2005 and II/2006″</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533817010292_497931"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1533817010292_497991"><div class="sqs-block-content"> <div class="sqs-html-content"> <h3 style="white-space:pre-wrap;">2006</h3><p style="white-space:pre-wrap;"><strong>Symposium “The need for standardisation of Immune Competence Assessment and Monitoring”</strong>, October 16, 2006, Cardiff, Wales – Oral presentation – <em>“Defining standardisation for immune monitoring”</em><br><br><strong>CIMT Annual Meeting</strong>, May 4-5, 2006, Mainz, Germany – Poster abstract P04 – <em>“The CIMT Monitoring Panel: Enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays”</em></p><p style="white-space:pre-wrap;"><strong>Progress in Vaccination against Cancer 2006 – PIVAC 6 meeting</strong>, September 28-29, 2006, Granada, Spain – Oral presentation – <em>“The CIMT monitoring panel: Standardization of in vitro methods for enumerating antigen specific CD8+ T lymphocytes”</em></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-90e965a99f7140e0bad6"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block code-block sqs-block-code" data-block-type="23" id="block-8de3bae1e35ba6dae1f5"><div class="sqs-block-content"><a href="#" class="btt">↑ BACK TO TOP</a></div></div><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1537974217547_20754"><div class="sqs-block-content"> <div class="sqs-html-content"> <p style="white-space:pre-wrap;"><a href="/news-1">→ NEWS</a> <a href="/about-cip-1">→ ABOUT CIP</a> <a href="/panels-and-workshops">→ PANELS AND WORKSHOPS</a> <a href="/research">→ RESEARCH</a> <a href="/cimt-annual-meeting">→ CIMT ANNUAL MEETING</a> <br><a href="/participants">→ PARTICIPANTS</a> <a href="/partners-supporters">→ PARTNERS & SUPPORTERS</a> <a href="/miata-1">→ MIATA</a></p> </div> </div></div></div><div class="col sqs-col-3 span-3"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-01831e6b0ceed400c908"><div class="sqs-block-content"> </div></div></div></div></div> </section> </main> </div> </div> <footer class="Footer" role="contentinfo" data-controller="FooterBreakpoints"> <div class="Footer-inner clear"> <div class="sqs-layout sqs-grid-12 columns-12 Footer-blocks Footer-blocks--top sqs-alternate-block-style-container" data-layout-label="Footer Top Blocks" data-type="block-field" data-updated-on="1732025648603" id="footerBlocksTop"><div class="row sqs-row"><div class="col sqs-col-12 span-12"><div class="row sqs-row"><div class="col sqs-col-3 span-3"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-yui_3_17_2_1_1529586133682_20980"><div class="sqs-block-content"> </div></div></div><div class="col sqs-col-6 span-6"><div class="sqs-block html-block sqs-block-html" data-block-type="2" id="block-yui_3_17_2_1_1530248587920_20494"><div class="sqs-block-content"> <div class="sqs-html-content"> <p style="text-align:center;white-space:pre-wrap;" class=""><a href="/bylaws/#imprint" target="_blank"><strong>IMPRINT</strong></a><strong> | </strong><a href="/bylaws"><strong>ASSOCIATION BY-LAWS</strong></a><strong> | </strong><a href="/privacy-policy" target="_blank"><strong>PRIVACY POLICY</strong></a><strong> </strong></p> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533652189250_252854"><div class="sqs-block-content"><hr /></div></div><div class="sqs-block button-block sqs-block-button" data-block-type="53" id="block-yui_3_17_2_1_1530248587920_12561"><div class="sqs-block-content"> <div class="sqs-block-button-container sqs-block-button-container--center" data-animation-role="button" data-alignment="center" data-button-size="small" data-button-type="tertiary" > <a href="https://cimt.us9.list-manage.com/subscribe?u=bb4ebd167f23f4ab06a109d92&id=31663cb050" class="sqs-block-button-element--small sqs-button-element--tertiary sqs-block-button-element" target="_blank" > Subscribe to CIMT Newsletter </a> </div> </div></div><div class="sqs-block horizontalrule-block sqs-block-horizontalrule" data-block-type="47" id="block-yui_3_17_2_1_1533652189250_172380"><div class="sqs-block-content"><hr /></div></div><div class="row sqs-row"><div class="col sqs-col-2 span-2"><div class="sqs-block spacer-block sqs-block-spacer" data-aspect-ratio="18.181818181818183" data-block-type="21" id="block-yui_3_17_2_1_1533652189250_235649"><div class="sqs-block-content"> </div></div></div><div class="col sqs-col-0 span-0"></div><div class="col sqs-col-2 span-2"><div class="sqs-block image-block sqs-block-image" data-aspect-ratio="100" data-block-type="5" id="block-yui_3_17_2_1_1530780528134_45591"><div class="sqs-block-content"> <div class=" image-block-outer-wrapper layout-caption-hidden design-layout-inline combination-animation-none individual-animation-none individual-text-animation-none " data-test="image-block-inline-outer-wrapper" > <figure class=" sqs-block-image-figure intrinsic " style="max-width:30px;" > <a class=" sqs-block-image-link " href="https://www.linkedin.com/company/cimt/" target="_blank" > <div class="image-block-wrapper" data-animation-role="image" > <div class="sqs-image-shape-container-element has-aspect-ratio " style=" position: relative; padding-bottom:100%; overflow: hidden;-webkit-mask-image: -webkit-radial-gradient(white, black); " > <img data-stretch="false" data-src="https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png" data-image="https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png" data-image-dimensions="30x30" data-image-focal-point="0.5,0.5" alt="icon-linkedin.png" data-load="false" elementtiming="system-image-block" src="https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png" width="30" height="30" alt="" sizes="(max-width: 640px) 100vw, (max-width: 767px) 16.666666666666664vw, 16.666666666666664vw" style="display:block;object-fit: cover; width: 100%; height: 100%; object-position: 50% 50%" onload="this.classList.add("loaded")" srcset="https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=100w 100w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=300w 300w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=500w 500w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=750w 750w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=1000w 1000w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=1500w 1500w, https://images.squarespace-cdn.com/content/v1/5b291a7ef2e6b15350bc6d77/1530781373501-9U63LRPTU9XE0T5TKNF4/icon-linkedin.png?format=2500w 2500w" loading="lazy" decoding="async" data-loader="sqs"> </div> </div> </a> </figure> </div> </div></div></div><div class="col sqs-col-2 span-2"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-yui_3_17_2_1_1533652189250_177466"><div class="sqs-block-content"> </div></div></div></div></div><div class="col sqs-col-3 span-3"><div class="sqs-block spacer-block sqs-block-spacer sized vsize-1" data-block-type="21" id="block-yui_3_17_2_1_1533652189250_156860"><div class="sqs-block-content"> </div></div></div></div></div></div></div> <div class="Footer-middle"> <div class="Footer-business"> </div> <div class="sqs-layout sqs-grid-12 columns-12 Footer-blocks Footer-blocks--middle sqs-alternate-block-style-container empty" data-layout-label="Footer Middle Blocks" data-type="block-field" data-updated-on="1529488297300" id="footerBlocksMiddle"><div class="row sqs-row"><div class="col sqs-col-12 span-12"></div></div></div> </div> <div class="sqs-layout sqs-grid-12 columns-12 Footer-blocks Footer-blocks--bottom sqs-alternate-block-style-container empty" data-layout-label="Footer Bottom Blocks" data-type="block-field" data-updated-on="1529587852460" id="footerBlocksBottom"><div class="row sqs-row"><div class="col sqs-col-12 span-12"></div></div></div> </div> </footer> </div> <script src="https://static1.squarespace.com/static/ta/55f0a9b0e4b0f3eb70352f6d/354/scripts/site-bundle.js" type="text/javascript"></script> <script data-sqs-type="imageloader-bootstrapper">if(window.ImageLoader) window.ImageLoader.bootstrap({}, document);</script><script>Squarespace.afterBodyLoad(Y);</script> </body> </html>